MicroRNA Biomarkers for Alzheimers Disease

Case ID:
2305
Web Published:
8/1/2017
Description:

A method to assess the presence of Alzheimer’s disease in a human by obtaining a sample of cerebrospinal fluid and extracting total RNA to determine the expression levels of extracellular micro RNA biomarkers.

 

A US provisional patent application filed 8/19/2016. A PCT patent application filed 8/18/2017.

 

Patent Information:
Category(s):
Diagnostics
For Information, Contact:
Michele Gunness
Senior Technology Development Manager
Oregon Health & Science University
(503) 494-8200
gunnessm@ohsu.edu
Inventors:
Julie Saugstad
Joseph Quinn
Jodi Lapidus
Christina (chris) Harrington
Theresa Ann Lusardi
Jay Phillips
Jack Wiedrick
Babett (betty) Lind
Keywords:
Diagnostics
Diagnostics - Neurology
© 2018. All Rights Reserved. Powered by Inteum